AAV Vector Manufacturing: Solving Gene Therapy's Bottleneck
Discover how innovations in AAV vector manufacturing are improving scalability, quality, and commercial readiness for next-generation gene therapies.
Foundational AI In Cell and Gene Therapy Development Success
Discover why AI in cell and gene therapy is necessary for successful development by improving drug discovery, viral vector engineering, manufacturing, and quality control.
Has Claude Found the Next CRISPR? Not Yet
Has Claude found the next CRISPR? Anthropic’s ART enzyme system looks CRISPR-like, but its function is unknown. Learn what pharma should watch for.
FDA Sets a New Direction for CGT Potency Assurance
The FDA’s new final guidance for cell and gene therapy potency assurance sets out a lifecycle, risk-based approach to product quality and manufacturing control.
Using Machine Learning for Lipid Nanoparticle Design
Read about machine learning for lipid nanoparticle design used to improve cell, gene, and RNA drug delivery and help optimise next-generation therapeutics.
Could Dry mRNA Vaccine Patches Eliminate the Cold Chain?
Discover how dry mRNA vaccine patches could reduce cold chain dependence, improve vaccine stability, and reshape pharmaceutical manufacturing and distribution.